The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    Testing Hyponidd, an Ayurvedic compound, to treat type 2 diabetes

    It lowered fasting and postprandial blood sugar levels and glycosylated hemoglobin (A1c) levels — but not significantly.

    First, the details.

    • 40 adults with type 2 diabetes and A1c levels greater than 8.5% (less than 7% is the target) after treatment with conventional antidiabetes drugs.
    • They were randomly assigned to Hyponidd 2 tablets taken 3 times a day for 3 months or a placebo.
    • Patients and the researchers did not know the treatment assignment.
    • Other drugs to treat diabetes or other diseases were continued.

    And, the results.

    • Changes in the fasting blood sugar levels and the blood sugar levels after a meal (postprandial) did not change significantly.
    • A1c levels also failed to change significantly.

    The bottom line?
    This is the second study (according to these authors) where Hyponidd failed to make a significant change in diabetes control.

    The researchers hold out hope that perhaps the failure to respond had something to do with the possibility that these patients were “resistant” to diabetes treatment.

    Maybe, but in the absence of any studies with positive outcomes how can a dispassionate observer come to any conclusion other than Hyponidd is not an effective treatment for type 2 diabetes?

    The ingredients in Hyponidd include Vijaysar (Pterocarpus marsupium), Gurmar (Gymneme Sylvestre), Jambu Beej (syzigium Cumine), Amla (Emblica Officianale), Haldi (Gurcuma Longa), Neem (Melia Azadirachta), Trivang Bhasma and Shilajit.

    7/8/07 9:40 JR

    Leave a Comment

    You must be logged in to post a comment.